View Older Stories View More Recent Stories

Nov 17, 2015 07:44AM Roth Capital Cuts Price Target on Marathon Patent Group (MARA) Following 3Q Beat

Nov 16, 2015 03:40PM Roth Lifts PT on Hydrogenics (HYGS) to $13 Following 'Milestone' Order

Nov 16, 2015 10:51AM Notable Analyst Rating Changes 11/16: (APH) (CEMP) (LLY) Upgraded; (MNKD) (CWEI) (CDTI) Downgraded

Nov 16, 2015 10:42AM Higher Shares Outstanding Offset CorMedix (CRMD) Revenue Miss; Roth Capital Remains Neutral

Nov 16, 2015 08:19AM Weak Oil Prices Weigh on Superior Drilling Products (SDPI); Roth Capital Remains Neutral

Nov 16, 2015 08:14AM Roth Capital Cuts Price Target on Flamel Technologies (FLML) Following Slight 3Q Miss

Nov 16, 2015 08:04AM Juniper Pharma (JNP) Announces Pipeline Candidates at Analyst Day; Roth Capital Reiterates Buy

Nov 16, 2015 06:53AM Roth Capital Downgrades Clean Diesel Technologies (CDTI) to Neutral

Nov 16, 2015 06:52AM Roth Capital Downgrades Clayton Williams Energy (CWEI) to Sell

Nov 13, 2015 02:04PM Roth Reaffirms VBL Therapeutics (VBLT) at 'Buy'; Financing Overhang Removed, Partnership Now Key Focus

Nov 13, 2015 11:02AM Notable Analyst Rating Changes 11/13: (BBG) (WMT) (YELP) Upgraded; (FFIV) (FME) (RBY) Downgraded

Nov 13, 2015 09:01AM 3Q Results Show Disparity in Così's (COSI) Best and Worst Performing Stores; Roth Capital Reiterates Buy

Nov 13, 2015 08:46AM Alcobra Ltd. (ADHD) Prices 6.18M Ordinary Stock Offering at $6.50/Share

Nov 13, 2015 08:45AM Alcobra Ltd. Prices Public Offering of Ordinary Shares

Nov 13, 2015 08:45AM Alcobra Ltd. Prices Public Offering of Ordinary Shares

Nov 13, 2015 07:47AM RAVE Restaurant Group (RAVE) Reports Rough Same Store Comps; Roth Capital Cuts Price Target to $14

Nov 13, 2015 06:47AM Roth Capital Starts Outerwall Inc. (OUTR) at Buy

Nov 13, 2015 06:34AM Roth Capital Starts Glu Mobile (GLUU) at Buy

Nov 13, 2015 06:33AM Roth Capital Downgrades Digital Ally (DGLY) to Neutral Following Disappointing Q3

Nov 12, 2015 08:47AM Roth Capital Raises Price Target on Future Fuel (FF) Following 3Q Revenue Beat

Nov 12, 2015 07:34AM FX Hits Middleby Corp's (MIDD) Net Sales; Roth Capital Cuts Price Target to $130

Nov 12, 2015 07:24AM Good Execution by Horizon Global (HZN) Drives Revenue Growth; Roth Capital Raises price Target to $13

Nov 12, 2015 07:00AM Telesta Therapeutics Publishes its Q1, 2016 Financial Statements and Provides Corporate Updates

Nov 11, 2015 02:11PM APTO-253 Remains in Focus for Aptose Biosciences (APTO); Roth Affirms at 'Buy'

Nov 11, 2015 07:56AM Zosano Pharma (ZSAN) Reported 3Q EPS Miss; Roth Capital Reiterates Buy

Nov 11, 2015 07:47AM 3Q EPS Miss Driven by Decline in Revenue; Roth Capital Reiterates Buy on Iconix Brand Group (ICON)

Nov 11, 2015 07:39AM Hydrogenics (HYGS) Reports Mixed 3Q Results; Roth Capital Reiterates Buy

Nov 11, 2015 07:30AM Roth Capital Reiterates Buy on Canadian Solar (CSIQ) Following 3Q

Nov 11, 2015 07:19AM Hackett Group, Inc. (HCKT) Shows Strength in North America; Roth Capital Raises Price Target to $18

Nov 11, 2015 06:49AM Canadian Solar (CSIQ) Capacity Expansion Continues Accelerating; Roth Affirms at 'Buy'

Nov 10, 2015 09:18AM Roth Trims PT on Galena (GALE) Following Q3 Results, Plans to Spin Commercial Assets

Nov 10, 2015 07:39AM Roth Capital Cuts Price Target on Exar Corp. (EXAR) Following In-Line 2Q Results

Nov 9, 2015 02:54PM Curis (CRIS) Outpaces in Q3; Roth Affirms 'Buy' Rating Ahead of ASH

Nov 9, 2015 02:20PM TG Therapeutics' (TGTX) Q3 Results Solid; Roth Remains Positive into ASH Conference

Nov 9, 2015 09:00AM ROTH Capital Partners Honored by Global M&A Network

Nov 9, 2015 08:40AM Roth Capital Cuts Price Target on Cytori Therapeutics (CYTX) Following 3Q15

Nov 9, 2015 07:32AM Cytokinetics (CYTK) and Amgen Inc. (AMGN) Announce COSMIC-HF Data; Roth Capital Raises Price Target to $22

Nov 9, 2015 07:00AM RedHill Biopharma Reports Results for the Third Quarter of 2015

Nov 6, 2015 09:41AM First Data from Rexahn's (RNN) Archexin Phase 2a Release; Appears Right on Track - Roth

Nov 6, 2015 09:13AM Vascular Biogenics Ltd. Announces Closing of $15 Million Underwritten Offering of Ordinary Shares and Warrants

Nov 6, 2015 09:05AM Pixelworks to Participate at ROTH Technology Corporate Access Day on November 18

Nov 6, 2015 09:00AM Adesto Technologies to Participate at ROTH New York Technology Corporate Access Day on November 18

Nov 6, 2015 08:37AM Skullcandy's (SKUL) Higher-Than-Expected Gross Margin Offset Low Revenue; Roth Capital Reiterates Buy

Nov 6, 2015 08:17AM Sarepta (SRPT) Conditional-Approval Thesis Unchanged, Roth Capital Says

Nov 6, 2015 08:11AM Roth Capital Starts Dimension Therapeutics (DMTX) at Buy

Nov 6, 2015 08:10AM Roth Capital Downgrades Constant Contact (CTCT) to Sell Amid Pending Takeover

Nov 5, 2015 04:30PM Intec Pharma Reports Results for the Third Quarter of 2015

Nov 5, 2015 01:27PM bluebird bio (BLUE) LentiGlobin is Here To Stay, Roth Capital Says; PT Cut to $165

Nov 5, 2015 12:19PM Streetinsider.com's Hot Lunchtime Reads 11/5: (VRX) (CAB) (QCOM) (BLRX) (RNWK)

Nov 5, 2015 11:51AM BioLineRx's (BLRX) Latest BL-8040 Phase 2 Data in r/r AML is 'Intriguing' - Roth Capital

View More Recent Stories View Older Stories